The Fermentation, Isolation and Characterization of a Macromolecular Peptide Antibiotic: An-1.

Journal of Antibiotics - United Kingdom
doi 10.7164/antibiotics.37.27
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japan Antibiotics Research Association

Related search

The Fermentation, Isolation and Characterization of a Macromolecular Peptide Antibiotic: AN-3.

Journal of Antibiotics
Drug DiscoveryPharmacology
1983English

Screening, Fermentation, Isolation, and Characterization of Trypanomycin, a New Antibiotic

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1972English

Isosulfazecin, a New .BETA.-lactam Antibiotic, Produced by an Acidophilic Pseudomonad. Fermentation, Isolation and Characterization.

Journal of Antibiotics
Drug DiscoveryPharmacology
1981English

Chryscandin, a Novel Peptidyl Nucleoside Antibiotic. I Taxonomy, Fermentation, Isolation and Characterization.

Journal of Antibiotics
Drug DiscoveryPharmacology
1984English

Tetrafungin, a New Polyene Macrolide Antibiotic. I. Fermentation, Isolation, Characterization, and Biological Properties.

Journal of Antibiotics
Drug DiscoveryPharmacology
1983English

Isolation, Structural Characterization, and Properties of Mattacin (Polymyxin M), a Cyclic Peptide Antibiotic Produced byPaenibacillus kobensisM

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2003English

Isolation and Characterization of a New Antibiotic U-62162.

Journal of Antibiotics
Drug DiscoveryPharmacology
1982English

Kijanimicin (Sch 25663), a Novel Antibiotic Produced by Actionmadura Kijaniata SCC 1256. Fermentation, Isolation, Characterization and Biological Properties.

Journal of Antibiotics
Drug DiscoveryPharmacology
1981English

Isolation and Characterization of Phosmidosine a New Antifungal Nucleotide Antibiotic.

Journal of Antibiotics
Drug DiscoveryPharmacology
1991English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy